Cargando…

Cerebral folate receptor autoantibodies in autism spectrum disorder

Cerebral folate deficiency (CFD) syndrome is a neurodevelopmental disorder typically caused by folate receptor autoantibodies (FRAs) that interfere with folate transport across the blood–brain barrier. Autism spectrum disorders (ASDs) and improvements in ASD symptoms with leucovorin (folinic acid) t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frye, R E, Sequeira, J M, Quadros, E V, James, S J, Rossignol, D A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578948/ https://www.ncbi.nlm.nih.gov/pubmed/22230883 http://dx.doi.org/10.1038/mp.2011.175

Ejemplares similares

Folate Receptor Alpha Autoantibodies in Autism Spectrum Disorders: Diagnosis, Treatment and Prevention
por: Bobrowski-Khoury, Natasha, et al.
Publicado: (2021)

Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis
por: Rossignol, Daniel A., et al.
Publicado: (2021)

Blocking and Binding Folate Receptor Alpha Autoantibodies Identify Novel Autism Spectrum Disorder Subgroups
por: Frye, Richard E., et al.
Publicado: (2016)

Treatment of Folate Metabolism Abnormalities in Autism Spectrum Disorder
por: Frye, Richard E., et al.
Publicado: (2020)

The Soluble Folate Receptor in Autism Spectrum Disorder: Relation to Autism Severity and Leucovorin Treatment
por: Frye, Richard E., et al.
Publicado: (2022)

Correction: Rossignol, D.A.; Frye, R.E. Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis. J. Pers. Med. 2021, 11, 1141
por: Rossignol, Daniel A., et al.
Publicado: (2022)

Oxidative Stress, Folate Receptor Autoimmunity, and CSF Findings in Severe Infantile Autism
por: Ramaekers, Vincent T., et al.
Publicado: (2020)

Environmental toxicants and autism spectrum disorders: a systematic review
por: Rossignol, D A, et al.
Publicado: (2014)

Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis
por: Rossignol, D A, et al.
Publicado: (2012)

Brain Uptake of Folate Forms in the Presence of Folate Receptor Alpha Antibodies in Young Rats: Folate and Antibody Distribution
por: Bobrowski-Khoury, Natasha, et al.
Publicado: (2023)

Treatments for Biomedical Abnormalities Associated with Autism Spectrum Disorder
por: Frye, Richard Eugene, et al.
Publicado: (2014)

Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes
por: Frye, Richard E., et al.
Publicado: (2016)

The Use of Medications Approved for Alzheimer’s Disease in Autism Spectrum Disorder: A Systematic Review
por: Rossignol, Daniel A., et al.
Publicado: (2014)

A Personalized Approach to Evaluating and Treating Autism Spectrum Disorder
por: Frye, Richard E, et al.
Publicado: (2022)

The Effectiveness of Cobalamin (B12) Treatment for Autism Spectrum Disorder: A Systematic Review and Meta-Analysis
por: Rossignol, Daniel A., et al.
Publicado: (2021)

Ratings of the Effectiveness of Nutraceuticals for Autism Spectrum Disorders: Results of a National Survey
por: Adams, James B., et al.
Publicado: (2021)

Hyperbaric oxygen treatment in autism spectrum disorders
por: Rossignol, Daniel A, et al.
Publicado: (2012)

Improving Outcome in Infantile Autism with Folate Receptor Autoimmunity and Nutritional Derangements: A Self-Controlled Trial
por: Ramaekers, Vincent Th., et al.
Publicado: (2019)

A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures
por: Rossignol, D A, et al.
Publicado: (2012)

Long COVID Syndrome Presenting as Neuropsychiatric Exacerbations in Autism Spectrum Disorder: Insights for Treatment
por: Jyonouchi, Harumi, et al.
Publicado: (2022)

Age-Related Changes in Epilepsy Characteristics and Response to Antiepileptic Treatment in Autism Spectrum Disorders
por: Gundogdu, Beliz Su, et al.
Publicado: (2023)

Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder
por: Rose, Shannon, et al.
Publicado: (2018)

A Systematic Review and Meta-Analysis of Immunoglobulin G Abnormalities and the Therapeutic Use of Intravenous Immunoglobulins (IVIG) in Autism Spectrum Disorder
por: Rossignol, Daniel A, et al.
Publicado: (2021)

The potential role of nitrous oxide in the etiology of autism spectrum disorder
por: Frye, R E, et al.
Publicado: (2016)

High-throughput autoantibody screening identifies differentially abundant autoantibodies in autism spectrum disorder
por: Mesleh, Areej, et al.
Publicado: (2023)

Absorption and Tissue Distribution of Folate Forms in Rats: Indications for Specific Folate Form Supplementation during Pregnancy
por: Bobrowski-Khoury, Natasha, et al.
Publicado: (2022)

Antigenic Targets of Patient and Maternal Autoantibodies in Autism Spectrum Disorder
por: Mazón-Cabrera, Rut, et al.
Publicado: (2019)

Editorial: Comorbidity and Autism Spectrum Disorder
por: Casanova, Manuel F., et al.
Publicado: (2020)

Cerebral Folate Deficiency Syndrome: Early Diagnosis, Intervention and Treatment Strategies
por: Ramaekers, Vincent Th., et al.
Publicado: (2022)

The Rationale for Vitamin, Mineral, and Cofactor Treatment in the Precision Medical Care of Autism Spectrum Disorder
por: Indika, Neluwa-Liyanage R., et al.
Publicado: (2023)

Metabolomic Signatures of Autism Spectrum Disorder
por: Brister, Danielle, et al.
Publicado: (2022)

Neuropathological Mechanisms of Seizures in Autism Spectrum Disorder
por: Frye, Richard E., et al.
Publicado: (2016)

Clinical potential, safety, and tolerability of arbaclofen in the treatment of autism spectrum disorder
por: Frye, Richard E
Publicado: (2014)

A Personalized Multidisciplinary Approach to Evaluating and Treating Autism Spectrum Disorder
por: Frye, Richard E.
Publicado: (2022)

Novel maternal autoantibodies in autism spectrum disorder: Implications for screening and diagnosis
por: Mazón-Cabrera, Rut, et al.
Publicado: (2023)

Clinical and autoimmune features of a patient with autism spectrum disorder seropositive for anti—NMDA-receptor autoantibody
por: Gréa, Hélène, et al.
Publicado: (2017)

Traditional and non-traditional treatments for autism spectrum disorder with seizures: an on-line survey
por: Frye, Richard E, et al.
Publicado: (2011)

Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study
por: Frye, R E, et al.
Publicado: (2013)

Modern Biomarkers for Autism Spectrum Disorder: Future Directions
por: Jensen, Amanda R., et al.
Publicado: (2022)

Nuclear Peroxisome Proliferator-Activated Receptors (PPARs) as Therapeutic Targets of Resveratrol for Autism Spectrum Disorder
por: Barone, Rita, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fqs20ms6eb5dvngjsfrqe95kbd